Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice
- 1 August 2016
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 132, 165-169
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31370930)
- Science and Technology Commission of Shanghai Municipality (13431900600, 15XD1524900)
- Chinese Academy of Sciences (KFJ-EW-STS-098)
This publication has 39 references indexed in Scilit:
- Neutralizing Antibodies Induced by Recombinant Virus-Like Particles of Enterovirus 71 Genotype C4 Inhibit Infection at Pre- and Post-attachment StepsPLOS ONE, 2013
- A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challengeVaccine, 2012
- An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010BMC Infectious Diseases, 2011
- Detection, characterization and quantitation of Coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteinsJournal of Virological Methods, 2011
- Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in FinlandJournal of Clinical Virology, 2010
- Human enterovirus 71 and hand, foot and mouth diseaseEpidemiology and Infection, 2010
- Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007Journal of Clinical Virology, 2009
- Coxsackievirus A6 and Hand, Foot, and Mouth Disease, FinlandEmerging Infectious Diseases, 2009
- Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challengeVaccine, 2008
- Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000–2002Journal of Medical Microbiology, 2006